Freedom Leaf is Growing Through Acquisition and Investment

Freedom Leaf Inc. (OTCQB: FRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. Freedom Leaf, Inc. has been a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industries since 2014, founded by professionals with decades of combined experience in marijuana legalization advocacy. FRLF is building a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry.


In the U.S., 30 states have some form of legal medical cannabis use and 9 states have approved recreational cannabis use along with many municipalities. In November voters will decide on ballot proposals for recreational cannabis use in Michigan and N. Dakota. Utah and Missouri voters will be deciding if they want a medical marijuana law on their books.


Freedom Leaf Inc. also sells licenses to use the Freedom Leaf brand in different countries and states across the globe. The company has entered into three license agreements: for Spain and Portugal, for The Netherlands, and for Florida.


The company’ shares continue to zoom backed by the favorable impact of its recent announcements and the growing popularity of the industry.


Recent announcements:

Investment from Merida Capital:

On Oct 3rd, 2018, the company announced that it had received a significant investment from cannabis private equity firm Merida Capital Partners to expand its existing US sales channels further and accelerate its European hemp cultivation operations.


Freedom Leaf and Merida have also agreed in principal to a strategic partnership by which Merida will provide certain operational resources and support for both Freedom Leaf’s US hemp-based cannabidiol (CBD) sales efforts and their global cultivation operations.


Our members have booked up to 800% with our recent (2018) NASDAQ and NYSE small cap alerts. We will be initiating coverage on another exciting small cap security mid-week this week (10/14/18). View our recent picks, track record and sign up for our real time mobile/text alerts here –


Receiving an investment from a leading cannabis firm like Merida, which already has investments in key supply chain providers like KushCo, GrowGeneration and Emerald Scientific, is a solid validation of Freedom Leaf’s aggressive efforts to build a high-quality family of cannabidiol-based products. Furthermore, it is also an acknowledgment of the potential for the Valencia, Spain cultivation facility to become a significant supplier of both hemp and cannabis to European markets in the immediate future.



Acquisition of Tierra Science: 1st-year revenue projected in excess of $2,500,000


Before this on August 16th, the company confirmed a 100% acquisition of Tierra Science Global, LLC, a company specializing in health supplements supporting peak bio-energy levels in humans which are currently distributed via highly motivated direct sales teams and well-established affiliate programs in Europe, Asia, and the United States.

Freedom Leaf CEO, Cliff Perry is confident that Tierra will achieve new revenue highs expeditiously toward additional profits and an increase in shareholder value. “The affiliate model we are deploying for Tierra is expected to yield 150 product packages per week at an average price of $400 each, yielding $240,000 per month in revenues with a 24% net profit.  This would equate to $57,600 in profits from the affiliate model alone with conservative estimates for $2.88 million in yearly revenues,” states Perry



In a short span of time, FRLF has strengthened its market and operational profile significantly. The company is moving forward at a rapid pace on utilizing these mergers and acquisitions and building a solid foundation for its vertically-integrated, global hemp corporation to maximize both shareholder value and revenue growth.


About the Company: Freedom Leaf, Inc. (OTCQB: FRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. Freedom Leaf, Inc. is a fully-reporting and audited publicly-traded company under the symbol (OTCQB: FRLF). Freedom Leaf, Inc. has been a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industries since 2014, founded by professionals with over 200 years of combined experience in marijuana legalization advocacy. FRLF is building a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry.


Financial Results –

As per management, over the last two quarters, the company have been concentrating on cleaning up the balance sheet, reducing debt and increasing assets in preparation for additional acquisitions and their resulting revenue growth.


The following are the key takeaways from the Q3 report, between June 30, 2017, and March 31, 2018:


  • Revenue: Revenue was $56,254 for the three months ended March 31, 2018, compared to $254,084 for the three months ended March 31, 2017.
  • Profit: Net loss attributable to common shareholders was $1,561,141 for the three months ended March 31, 2018, compared to net loss of $27,200 for the three months ended March 31, 2017.
  • Liquidity and financial flexibility: As of March 31, 2018, the Company had $165,544 in cash. On Oct 3rd, the company confirmed that it received a significant investment from cannabis private equity firm Merida Capital Partners(“Merida”) to further expand its existing US sales channels and accelerate its European hemp cultivation operations.


Key risk factors and potential stock drivers:

  • Continuing growth in the cannabis sector could act as a catalyst for the company shares.
  • The company operation is still at a pre-commercialisation stage. Therefore, its ability to maintain liquidity and financial flexibility to fund its incremental capital requirements will remain an extremely critical challenge for the company.
  • The company’ business is exposed to risk related to competitive pressure, and its revenues may suffer from competitive pressure.
  • Notwithstanding the recent boom, this is still a very nascent stage space and only time would differentiate between real winners and laggards. As far as choosing an option with a relative advantage is concerned, FRLF is the preferred choice with upside potential.
  • Marijuana remains illegal under federal law. It is a Schedule I controlled substance. Even in those jurisdictions in which the use of medical marijuana has been legalized at the state level, its prescription is a violation of federal law.
  • The company’s business is exposed to regulatory risk and its adverse impact on the overall business risk profile.


Stock Performance


  • On Monday, October 15th, 2018, FRLF was at $.67, on an above average volume of 2.8million shares exchanging hands. Market capitalization is $116.651 million. The current RSI is 84.37
  • In the past 52 weeks, shares of FRLF have traded as low as $0.0265 and as high as $0.58
  • At $.67, shares of FRLF are trading above its 50-day moving average (MA) at $.21 & above its 200-day moving average (MA) at $0.18
  • The present support and resistance levels for the stock are at $0.3806 & $0.5986 respectively.



Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Traders News Source has not been compensated for this report by anyone and the opinions if any are that of the author Vikas Agrawal, CFA. Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I, wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article.
This web site, published by TNS LLC, and is an investment newsletter that is built on the premise of assisting individual investors in learning about investing. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers. TNS LLC does not give buy or sell recommendations. We do purchase distribution rights from analyst, financial writers and bloggers for a fee that may be licensed to issue price targets and recommendations. Furthermore, we encourage you to speak to a licensed professional prior to making an investment in any type of publicly traded security.
We do sell advertising to other companies including brokerage firms, web sites, publicly traded issuers, investor relations firms, and investment publications, among others. TNS LLC makes no warranty as to the policies of these organizations, and in no way endorses their offers, services, or the content of their advertisements.
When an advertiser is a publicly traded company or a third party acting on behalf of a public company, we fully disclose all compensation in the email advertisement. Such disclosure is included in a disclosure statement in each of the advertisements sent via email.
17B Disclosure
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.
TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur.
Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.